GMPharm (Private limited company)
GMPharm is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0781.862.362. It was founded on 11-02-2022. Its registered office is in Perwez. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 175 058 and a profit of € 55 459. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 18-10-2026.
Company information
Key figures of GMPharm
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € 55 459-5 % | € 58 453+29 % | € 45 412+82 % | € 25 000 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 175 058+33 % | € 131 364+80 % | € 72 912+165 % | € 27 500 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 215 626+27 % | € 169 291+80 % | € 94 094+114 % | € 44 068 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 73 251-5 % | € 76 860+29 % | € 59 670+83 % | € 32 527 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | - | - | - | - |
Financial estimate
Similar companies
Other companies in the same activity in Perwez.
| Company | Town |
|---|---|
| ANSERS | 1360 Perwez |
| STAPHYT BELGIQUE | 1360 Perwez |
| CARTACHE | 1360 Perwez |
| TYRIUM | 1360 Perwez |
| F & F | 1360 Perwez |
Frequently asked questions
Is GMPharm still active? Yes. The Crossroads Bank for Enterprises lists GMPharm as active.
What is the VAT number of GMPharm? The VAT number of GMPharm is BE 0781.862.362.
When was GMPharm founded? GMPharm was founded on 11-02-2022.
What is the address of GMPharm? The current registered office of GMPharm is Rue de Seumay 34, 1360 Perwez.
When did GMPharm last file annual accounts? The latest annual accounts of GMPharm were filed on 30-04-2026.
Does GMPharm file its annual accounts on time? Yes. GMPharm filed its annual accounts within the legal deadline for each of its last 4 financial years.
Is GMPharm financially healthy? Addrly gives GMPharm a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is GMPharm profitable? The annual accounts of GMPharm for 2025 show a profit of € 55 459.
What is the equity of GMPharm? The equity of GMPharm was € 175 058 at the close of the 2025 financial year.
Who are the directors of GMPharm? The annual accounts of GMPharm record 1 mandate. The name, role and dates are visible with a free account.
Can GMPharm receive Peppol e-invoices? Yes. GMPharm is registered on the Peppol network and can receive structured electronic invoices.
What does GMPharm do? The main activity of GMPharm is: Scientific research and development.